BRACHYTHERAPY IN LIP CARCINOMA: LONG-TERM RESULTS

被引:23
作者
Guibert, Mireille [1 ]
David, Isabelle [2 ]
Vergez, Sebastien [1 ]
Rives, Michel [2 ]
Filleron, Thomas [3 ]
Bonnet, Jacques [2 ]
Delannesy, Martine [2 ]
机构
[1] Larrey Hosp, Dept Head & Neck Surg, F-31400 Toulouse, France
[2] Claudius Regaud Inst, Dept Radiat Oncol, Toulouse, France
[3] Claudius Regaud Inst, Dept Epidemiol, Toulouse, France
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 05期
关键词
Lip carcinoma; Low-dose-rate brachytherapy; Local control; Relapse-free survival; SQUAMOUS-CELL CARCINOMA; DOSE-RATE BRACHYTHERAPY; RADIOTHERAPY; CANCER;
D O I
10.1016/j.ijrobp.2010.10.031
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The aim of this study was to evaluate the effectiveness of low-dose-rate brachytherapy for local control and relapse-free survival in squamous cell and basal cell carcinomas of the lips. We compared two groups: one with tumors on the skin and the other with tumors on the lip. Patients and methods: All patients had been treated at Claudius Regaud Cancer Centre from 1990 to 2008 for squamous cell or basal cell carcinoma. Low-dose-rate brachytherapy was performed with iridium 192 wires according to the Paris system rules. On average, the dose delivered was 65 Gy. Results: 172 consecutive patients were included in our study; 69 had skin carcinoma (squamous cell or basal cell), and 92 had squamous cell mucosal carcinoma. The average follow-up time was 5.4 years. In the skin cancer group, there were five local recurrences and one lymph node recurrence. In the mucosal cancer group, there were ten local recurrences and five lymph node recurrences. The 8-year relapse-free survival for the entire population was 80%. The 8-year relapse-free survival was 85% for skin carcinoma 75% for mucosal carcinoma, with no significant difference between groups. The functional results were satisfactory for 99% of patients, and the cosmetic results were satisfactory for 92%. Maximal toxicity observed was Grade 2. Conclusions: Low-dose-rate brachytherapy can be used to treat lip carcinomas at Stages T1 and T2 as the only treatment with excellent results for local control and relapse-free survival. The benefits of brachytherapy are also cosmetic and functional, with 91% of patients having no side effects. (C) 2011 Elsevier Inc.
引用
收藏
页码:E839 / E843
页数:5
相关论文
共 19 条
[1]   Lymphatic mapping and sentinel lymph node biopsy in squamous cell carcinoma of the lower lip [J].
Altinyollar, H ;
Berberoglu, U ;
Çelen, O .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2002, 28 (01) :72-74
[2]   BRACHYTHERAPY FOR LOWER LIP EPIDERMOID CANCER - TUMORAL AND TREATMENT FACTORS INFLUENCING RECURRENCES AND COMPLICATIONS [J].
BEAUVOIS, S ;
HOFFSTETTER, S ;
PEIFFERT, D ;
LUPORSI, E ;
CAROLUS, JM ;
DARTOIS, D .
RADIOTHERAPY AND ONCOLOGY, 1994, 33 (03) :195-203
[3]   Low dose rate brachytherapy in lip carcinoma [J].
Conill, C. ;
Verger, E. ;
Marruecos, J. ;
Vargas, M. ;
Biete, A. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2007, 9 (04) :251-254
[4]  
Cowen D, 1990, Bull Cancer Radiother, V77, P111
[5]   Surgical treatment of squamous cell carcinoma of the lower lip: Evaluation of long-term results and prognostic factors - A retrospective analysis of 184 patients [J].
de Visscher, JGAM ;
van den Elsaker, K ;
Grond, AJK ;
van der Wal, JE ;
van der Waal, I .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 1998, 56 (07) :814-820
[6]  
Fongione S, 1994, Radiol Med, V88, P657
[7]  
Gerbaulet A, 2001, PRINCIPLES PRACTICE, P284
[8]  
Gerbaulet A, 2002, GEC ESTRO HDB BRACHY, P227
[9]   Radiotherapy for cancer of the lip - A long-term evaluation of 85 treated cases [J].
Gooris, PJJ ;
Maat, B ;
Vermey, A ;
Roukema, JA ;
Roodenburg, JLN .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1998, 86 (03) :325-330
[10]   Lip cancer treatment with high dose rate brachytherapy [J].
Guinot, JL ;
Arribas, L ;
Chust, ML ;
Mengual, JL ;
Miragall, EG ;
Carrascosa, M ;
Escolar, PP ;
Crispín, V ;
Guardino, C .
RADIOTHERAPY AND ONCOLOGY, 2003, 69 (01) :113-115